← FDA DRUG APPROVALS
FDA ANDA · ANDA208136
NYSTATIN AND TRIAMCINOLONE ACETONIDE
Sponsor: GLENMARK PHARMS LTD
APPLICATION
ANDA208136
TYPE
ANDA
ORIGINAL APPROVAL
2016-10-24
LATEST ACTION
2016-10-24
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued
Products
NYSTATIN AND TRIAMCINOLONE ACETONIDEDiscontinued
NYSTATIN 100,000 UNITS/GM, TRIAMCINOLONE ACETONIDE 0.1% · CREAM · TOPICAL
Approval history
2016-10-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.